Every Patient Who Has a GI Cancer Should Be Tested for MSI-High Status
April 5th 2018With immunotherapy continuing to command headlines in the world of oncology, it’s no surprise that patients with a variety of cancers wonder whether the strategy might help them address and overcome their illnesses.
Chemo Regimen Helps Control Locally Advanced Pancreatic Cancer
March 23rd 2018“Disease control is key in our patients with locally advanced disease, as it may lead to opportunities for additional treatment interventions, including radiotherapy, or even, in some favorable cases, surgical resection,” said lead study author Pascal Hammel, M.D., Ph.D.
Immunotherapy After Targeted Drug Shows Promise in Advanced Liver Cancer
March 22nd 2018Treatment with the PD-1 inhibitor Keytruda (pembrolizuumab) elicited promising progression-free survival (PFS) and overall survival (OS) results in patients with advanced hepatocellular carcinoma (HCC) who received previous treatment with Nexavar (sorafenib), according to phase 2 findings.
Cabometyx Improves Survival in Patients With Advanced Hepatocellular Carcinoma
March 21st 2018“Patients with advanced hepatocellular carcinoma often have a poor prognosis and limited treatment options following prior systemic therapy,” lead investigator Ghassan K. Abou-Alfa, M.D.